BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 15734861)

  • 1. Requirement of aldose reductase for the hyperglycemic activation of protein kinase C and formation of diacylglycerol in vascular smooth muscle cells.
    Ramana KV; Friedrich B; Tammali R; West MB; Bhatnagar A; Srivastava SK
    Diabetes; 2005 Mar; 54(3):818-29. PubMed ID: 15734861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase.
    Ramana KV; Friedrich B; Srivastava S; Bhatnagar A; Srivastava SK
    Diabetes; 2004 Nov; 53(11):2910-20. PubMed ID: 15504972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells.
    Reddy AB; Ramana KV; Srivastava S; Bhatnagar A; Srivastava SK
    Endocrinology; 2009 Jan; 150(1):63-74. PubMed ID: 18772236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high glucose on mesangial cell protein kinase C-delta and -epsilon is polyol pathway-dependent.
    Kapor-Drezgic J; Zhou X; Babazono T; Dlugosz JA; Hohman T; Whiteside C
    J Am Soc Nephrol; 1999 Jun; 10(6):1193-203. PubMed ID: 10361857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation.
    Keogh RJ; Dunlop ME; Larkins RG
    Metabolism; 1997 Jan; 46(1):41-7. PubMed ID: 9005967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase-regulated tumor necrosis factor-alpha production is essential for high glucose-induced vascular smooth muscle cell growth.
    Ramana KV; Tammali R; Reddy AB; Bhatnagar A; Srivastava SK
    Endocrinology; 2007 Sep; 148(9):4371-84. PubMed ID: 17584970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells.
    Ramana KV; Friedrich B; Bhatnagar A; Srivastava SK
    FASEB J; 2003 Feb; 17(2):315-7. PubMed ID: 12490536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway.
    Shaw S; Wang X; Redd H; Alexander GD; Isales CM; Marrero MB
    J Biol Chem; 2003 Aug; 278(33):30634-41. PubMed ID: 12777386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxin-induced cardiomyopathy and systemic inflammation in mice is prevented by aldose reductase inhibition.
    Ramana KV; Willis MS; White MD; Horton JW; DiMaio JM; Srivastava D; Bhatnagar A; Srivastava SK
    Circulation; 2006 Oct; 114(17):1838-46. PubMed ID: 17030682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.
    Srivastava S; Ramana KV; Tammali R; Srivastava SK; Bhatnagar A
    Diabetes; 2006 Apr; 55(4):901-10. PubMed ID: 16567509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between aldose reductase enzyme and the signaling pathway of protein kinase C in an in vitro diabetic retinopathy model.
    Sarikaya M; Yazihan N; Daş Evcimen N
    Can J Physiol Pharmacol; 2020 Apr; 98(4):243-251. PubMed ID: 31743046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels.
    Kunisaki M; Bursell SE; Umeda F; Nawata H; King GL
    Diabetes; 1994 Nov; 43(11):1372-7. PubMed ID: 7926314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bradykinin and angiotensin II: activation of protein kinase C in arterial smooth muscle.
    Dixon BS; Sharma RV; Dickerson T; Fortune J
    Am J Physiol; 1994 May; 266(5 Pt 1):C1406-20. PubMed ID: 8203504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High glucose-induced mesangial cell altered contractility: role of the polyol pathway.
    Derylo B; Babazono T; Glogowski E; Kapor-Drezgic J; Hohman T; Whiteside C
    Diabetologia; 1998 May; 41(5):507-15. PubMed ID: 9628266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldose reductase mediates the mitogenic signals of cytokines.
    Ramana KV; Chandra D; Srivastava S; Bhatnagar A; Srivastava SK
    Chem Biol Interact; 2003 Feb; 143-144():587-96. PubMed ID: 12604244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyol pathway and protein kinase C activity of rat Schwannoma cells.
    Kamiya H; Nakamura J; Hamada Y; Nakashima E; Naruse K; Kato K; Yasuda Y; Hotta N
    Diabetes Metab Res Rev; 2003; 19(2):131-9. PubMed ID: 12673781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells.
    Ramana KV; Bhatnagar A; Srivastava SK
    FASEB J; 2004 Aug; 18(11):1209-18. PubMed ID: 15284221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia.
    Xia P; Inoguchi T; Kern TS; Engerman RL; Oates PJ; King GL
    Diabetes; 1994 Sep; 43(9):1122-9. PubMed ID: 8070612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E normalizes diacylglycerol-protein kinase C activation induced by hyperglycemia in rat vascular tissues.
    Kunisaki M; Fumio U; Nawata H; King GL
    Diabetes; 1996 Jul; 45 Suppl 3():S117-9. PubMed ID: 8674876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury.
    Ruef J; Liu SQ; Bode C; Tocchi M; Srivastava S; Runge MS; Bhatnagar A
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1745-52. PubMed ID: 10894812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.